We say "oh great, a Conference Call coming up" because we "expect" some meat in each CC. So I like the idea of a CC, but if there's no meat, just updates regarding waiting periods, well, that can be OK kind of. When there are multiple CCs with lack of meat, and we just need to wait and wait, then add that predicted time estimates are not met, that not only disappoints, but it provides fuel for shorts and bashers.

So I am with many here, who propose that this silence is OK, and Cytodyn is merely being thorough and careful, to do everything as near to perfect as possible, and newly hired folks may be extending substantil influence and improvements to assure the highest probability of covid-19 and HIV approvals.

Many or most of maybe nearly all long CYDY investors are invested to their personal max and beyond (like me) and thus are unable to fight against these declines in share price, and big investors refuse to enter pre-approvals. So again, a repeat, the data will be crucial and Secondary Endpoints, which require more time to organize and access, can help, but may contribute to the wait time.